Drugs / polyethylene glycol 3350 plus electrolytes
polyethylene glycol 3350 plus electrolytes
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00404040 | Oct 2000 → Jul 2002 | constipation disorder | Norgine | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | polyethylene glycol 3350 plus electrolytes | “OBJECTIVES: To assess the efficacy of polyethylene glycol 3350 plus electrolytes (PEG + E; Movicol) as oral monotherapy in the treatment of faecal impaction in children, and to...” PMID 16819379 ↗ Jul 2006 |
| Known as | Movicol | “OBJECTIVES: To assess the efficacy of polyethylene glycol 3350 plus electrolytes (PEG + E; Movicol) as oral monotherapy in the treatment of faecal impaction in children, and to...” PMID 16819379 ↗ Jul 2006 |
| Known as | PEG + E | “OBJECTIVES: To assess the efficacy of polyethylene glycol 3350 plus electrolytes (PEG + E; Movicol) as oral monotherapy in the treatment of faecal impaction in children, and to...” PMID 16819379 ↗ Jul 2006 |
| Known as | PGE + E | “Treatment of faecal impaction with polyethelene glycol plus electrolytes (PGE + E) followed by a double-blind comparison of PEG + E versus lactulose as maintenance therapy.” PMID 16819379 ↗ Jul 2006 |
| Route | Oral | “orally administered laxative” PMID 16819379 ↗ Jul 2006 |